| Pfizer Pumps $200M Into CStone for Rights to PD-L1 Cancer Drug in China | Frank Vinluan | 09/30/20 | New York |
| Bio Roundup: Grail Acquisition, Libra’s Launch, Tau Trial Results & More | Frank Vinluan | 09/25/20 | National |
| Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | Frank Vinluan | 09/11/20 | National |
| FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures | Frank Vinluan | 09/05/20 | Boston |
| Elevation Oncology Debuts With $32.5M to Develop Targeted Cancer Drugs | Sarah de Crescenzo | 07/21/20 | New York |
| Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More | Frank Vinluan | 07/17/20 | National |
| Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact | Frank Vinluan | 07/14/20 | Boston |
| Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More | Frank Vinluan | 05/22/20 | National |
| Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug | Frank Vinluan | 05/08/20 | Indiana |
| Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More | Sarah de Crescenzo | 04/03/20 | National |
| Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic | Frank Vinluan | 01/07/20 | Boston |
| The Winners of the 2019 Xconomy Awards Boston Are… | Jeff Bauter Engel | 09/12/19 | Boston |
| At Big Lung Cancer Meeting, Lights Shine on KRAS, Drug Combos & More | Ben Fidler | 09/09/19 | National |
| Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug | Ben Fidler | 08/13/19 | Boston |
| The Finalists for the 2019 Xconomy Awards Are … | Angela Shah | 07/10/19 | Boston |
| ASCO 2019: The Long Game, Targeted Pills, First-Ever Buzz & More | Alex Lash | 06/05/19 | National |
| What’s Hot in Boston Biotech 2019: The Photos | Jeff Bauter Engel | 06/04/19 | Boston |
| Register Today and Save on “What’s Hot in Boston Biotech” on May 21 | Ashley Gentile | 05/10/19 | Boston |
| Gene Therapy Boom, Cracking Alzheimer’s: What’s Hot on May 21 | Ashley Gentile | 03/14/19 | Boston |
| Genetic Medicine: FDA OKs 2nd Cancer Drug That Targets DNA, Not Tissues | Ben Fidler | 11/26/18 | National |
| Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More | Frank Vinluan | 11/16/18 | National |
| Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More | Ben Fidler | 09/28/18 | National |
| Catch CRISPR 2.0, RNA-Targeting Drugs & More At “Disruptors” on Oct. 17 | Ben Fidler | 09/26/18 | Boston |
| Another Precision Step for Roche as Ignyta Drug Heads to Regulators | Ben Fidler | 09/24/18 | San Francisco |
| Inclusion in Labs, the C-Suite & More: Xconomy Awards Diversity Finalists | Frank Vinluan | 08/09/18 | Boston |
| The 2018 Xconomy Awards Finalists Are… | Corie Lok | 06/28/18 | Boston |
| Loxo Unveils More Data, Paves a Path Forward In Precision Oncology | Ben Fidler | 06/02/18 | National |
| Bio Roundup: ASCO Abstracts, Migraine Drug Prices & “Blueprint” Fallout | Alex Lash | 05/18/18 | National |
| Startup Builders, IPO Closers & More: Meet Xconomy’s CEO Award Finalists | Ben Fidler | 08/10/17 | Boston |
| Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps | Ben Fidler | 07/28/17 | National |
